The novel adipocytokine visfatin exerts direct cardioprotective effects
Visfatin is an adipocytokine capable of mimicking the glucose‐lowering effects of insulin and activating the pro‐survival kinases phosphatidylinositol‐3‐OH kinase (PI3K)‐protein kinase B (Akt) and mitogen‐activated protein kinase kinase 1 and 2 (MEK1/2)‐extracellular signal‐regulated kinase 1 and 2...
Saved in:
Published in | Journal of cellular and molecular medicine Vol. 12; no. 4; pp. 1395 - 1403 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.08.2008
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!